Corporate
Top
Terumo Key Policies Regarding COVID-19
- 1.To protect the health and safety of all Terumo Associates with utmost priority.
- 2.To maintain a stable supply of products to continuously meet global healthcare needs.
- 3.To actively engage and contribute to the prevention and treatment of the disease, by maximizing Terumo Group's expertise and technologies.
Message from Management
We offer our deepest condolences for the people who have lost their lives during this time due to COVID-19, and pray for the recovery of others who have been afflicted by the virus.
With the three key policies of (1) ensuring the health and safety of all Terumo Associates, (2) maintaining a stable supply of products, and (3) actively contributing to prevention and treatment of the disease, the entire Terumo Group continues to work in the fight against COVID-19 to support medical professionals on the front lines and continue bringing treatment to patients.
Dr. Shibasaburo Kitasato, one of Terumo’s founders, dedicated his life to infectious disease prevention and microbiological research. Having inherited his DNA, Terumo has a long history of working to fight infectious diseases. In the COVID-19 crisis, we are reminded of the true meaning of our Group Mission of "Contributing to Society through Healthcare," and strongly feel a renewed sense of our purpose as a company—to keep working to bring solutions to medical settings.
In the post-COVID-19 world as well, the Terumo Group will continue to contribute to the health and safety globally.
President and CEO
Shinjiro Sato
Terumo Group Efforts
Learn more about our actions related to (responses to) COVID-19
Past Announcements on COVID-19
Donations
As the world joins together to support healthcare workers and others on the front lines providing critical care to patients, Terumo has donated over USD 4 million in cash and products to support the COVID-19 relief efforts worldwide - including a USD 2 million donation to the COVID-19 Solidarity Response Fund for WHO and donating a large number of digital thermometers and vital cardiopulmonary support systems (ECMO, or Extracorporeal Membrane Oxygenation) to medical institutions.